Q2 2026 Holdings
Filed 2026-08-14 | 63 holdings | $1.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $340.0M | 10,876,219 | 25.6% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $93.6M | 500,000 | 7.1% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $80.6M | 605,000 | 6.1% |
| Uniqure NV(QURE) | SHS | N90064101 | $69.2M | 1,503,300 | 5.2% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $57.6M | 1,477,600 | 4.3% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $49.2M | 429,100 | 3.7% |
| Definium Therapeutics Inc(DFTX) | COM SHS | 24477V105 | $47.0M | 998,500 | 3.5% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $44.1M | 3,983,000 | 3.3% |
| Celcuity Inc(CELC) | COM | 15102K100 | $43.6M | 416,530 | 3.3% |
| Q32 BIO Inc(QTTB) | COM | 746964105 | $40.1M | 3,149,310 | 3.0% |
| Capricor Therapeutics Inc(CAPR) | COM NEW | 14070B309 | $33.6M | 1,395,156 | 2.5% |
| Precigen Inc(PGEN) | COM | 74017N105 | $29.4M | 5,150,000 | 2.2% |
| Corcept Therapeutics Inc(CORT) | COM | 218352102 | $29.2M | 335,500 | 2.2% |
| Surrozen Inc.(SRZN) | COM NEW | 86889P208 | $27.0M | 1,105,683 | 2.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $20.8M | 170,000 | 1.6% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $19.0M | 1,866,000 | 1.4% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $18.9M | 325,000 | 1.4% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $18.4M | 500,000 | 1.4% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $16.4M | 1,100,000 | 1.2% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $16.3M | 200,000 | 1.2% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $15.6M | 46,457 | 1.2% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $14.4M | 800,000 | 1.1% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $12.8M | 1,300,000 | 1.0% |
| Opus Genetics Inc(IRD) | COM | 67577R102 | $11.6M | 2,815,000 | 0.9% |
| Palisade BIO Inc(PALI) | COM | 696389402 | $10.0M | 4,799,875 | 0.8% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $9.3M | 70,000 | 0.7% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $8.9M | 100,000 | 0.7% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $8.7M | 225,000 | 0.7% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $8.5M | 100,000 | 0.6% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $8.4M | 450,000 | 0.6% |
| Crescent Biopharma Inc. | COM | 38000Q201 | $8.2M | 453,686 | 0.6% |
| Contineum Therapeutics Inc(CTNM) | CL A | 21217B100 | $8.1M | 494,000 | 0.6% |
| Kazia Therapeutics LTD | SPONSORED ADS | 48669G303 | $7.9M | 560,000 | 0.6% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $6.9M | 1,000,000 | 0.5% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $6.9M | 375,000 | 0.5% |
| Forte Biosciences Inc(FBRX) | COM NEW | 34962G208 | $5.8M | 274,500 | 0.4% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $5.8M | 842,106 | 0.4% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $5.4M | 275,000 | 0.4% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $5.3M | 900,000 | 0.4% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $5.2M | 790,000 | 0.4% |
| Odyssey Therapeutics Inc(ODTX) | COMMON STOCK | 67613T104 | $5.1M | 275,000 | 0.4% |
| Immatics N.v(IMTX) | SHS | N44445109 | $4.8M | 475,000 | 0.4% |
| Faeth Therapeutics inc(SNSE) | COM NEW | 81728A207 | $4.5M | 180,505 | 0.3% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $4.0M | 75,000 | 0.3% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $3.8M | 350,000 | 0.3% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $3.6M | 749,035 | 0.3% |
| Neumora Therapeutics Inc.(NMRA) | COM | 640979100 | $3.4M | 2,000,000 | 0.3% |
| Inovio Pharmaceuticals Inc(INO) | COM SHS | 45773H409 | $3.1M | 2,844,994 | 0.2% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $3.1M | 1,500,000 | 0.2% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $3.0M | 300,000 | 0.2% |